THERAPEUTIC DRUG FOR PNEUMONIA
The inventors of the present invention found that a peptide derived from HMGB1 can be used for non-conventional applications such as treatment of pneumonia. The present application provides a non-conventional application of a peptide derived from HMGB1 on the basis of this knowledge. Les inventeurs...
Saved in:
Main Authors | , , , |
---|---|
Format | Patent |
Language | English French Japanese |
Published |
16.03.2023
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The inventors of the present invention found that a peptide derived from HMGB1 can be used for non-conventional applications such as treatment of pneumonia. The present application provides a non-conventional application of a peptide derived from HMGB1 on the basis of this knowledge.
Les inventeurs de la présente invention ont découvert qu'un peptide dérivé de HMGB1 peut être utilisé pour des applications non classiques telles que le traitement de la pneumonie. La présente demande concerne une application non classique d'un peptide dérivé de HMGB1 sur la base de cette connaissance.
本発明者らは、HMGB1に由来するペプチドが、肺炎の治療用途等の従来とは異なる用途に用いることができることを見出した。この知見に基づき、本願は、HMGB1に由来するペプチドの従来とは異なる用途を提供する。 |
---|---|
Bibliography: | Application Number: WO2021JP34806 |